Signet Healthcare Partners
New York, New York, United StatesFounded 1998
Signet Healthcare Partners is a New York-based growth equity firm founded in 1998 that provides growth capital to innovative, commercial-stage healthcare companies. The firm focuses on specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics, with typical investments of $10-50 million.
Their most common stage is series-b (50% of deals). Average disclosed round size is $29.9M (across 9 rounds with reported amounts).
Portfolio
14
Fund Size
$137.2M
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PParagonix Technologies | Series B | $24M | Jan 2023 |
| Lleon-nanodrugs GmbH | Series B | — | Apr 2020 |
 Smart Medical Systems Ltd. | Series B | $8M | Feb 2018 |
| SSmart Medical Systems | Series B | $8M | Feb 2018 |
| LLeading Pharma, LLC | Growth | $40M | Jan 2018 |
| PPharmaceutics International Inc. (Pii) | Unknown | $93M | Jan 2016 |
| CChr. Olesen Synthesis | Series A | — | Oct 2015 |
| LLeon Nanodrugs | Series A | — | Jul 2015 |
 Arbor Pharmaceuticals | Series B | $34.8M | Nov 2010 |
| PPEAK Surgical | Series C | $21M | Feb 2008 |
| BBioject Medical Technologies | Unknown | $600K | Dec 2007 |
| KKew Group | Series B | — | — |
| AAlpex Pharma | Series B | — | — |
| LLeading Pharma | Growth | $40M | — |
Top Co-Investors
TVM Capital Life Science2 shared
Crestline Investors2 shared
BayBG Bayerische Beteiligungsgesellschaft mbH1 shared
JW Asset Management1 shared
Domain Associates1 shared
Venrock1 shared
Last updated: 8 September 2026